CD1D and hematologic disorder: Further advantages of CAR iNKT cells are that they are distinct cells that can be isolated and expanded, recognize a unique marker CD1d that is frequently expressed on hematological malignancies and have cytotoxic capacity that may be augmented through other ligands (1, 5, 9).